A population pharmacokinetic model to predict the individual starting dose of tacrolimus in adult renal transplant recipients-Reference-Cited by-同舟云学术

A population pharmacokinetic model to predict the individual starting dose of tacrolimus in adult renal transplant recipients

Published:2019-01-17 Issue:3 Volume:85 Page:601-615
ISSN:0306-5251
Container-title:British Journal of Clinical Pharmacology
language:en
Short-container-title:Br J Clin Pharmacol

Author:

Andrews L. M.¹^ORCID,Hesselink D. A.²³^ORCID,Schaik R. H. N.⁴^ORCID,Gelder T.¹²³^ORCID,Fijter J. W.⁵^ORCID,Lloberas N.⁶^ORCID,Elens L.⁷^ORCID,Moes D. J. A. R.⁸^ORCID,Winter B. C. M.¹^ORCID

Affiliation:

1. Department of Hospital Pharmacy, Erasmus MCUniversity Medical Center Rotterdam Rotterdam the Netherlands

2. Department of Internal Medicine, Division of Nephrology & Transplantation, Erasmus MCUniversity Medical Center Rotterdam Rotterdam The Netherlands

3. Rotterdam Transplant Group Rotterdam The Netherlands

4. Department of Clinical Chemistry, Erasmus MCUniversity Medical Center Rotterdam Rotterdam The Netherlands

5. Department of NephrologyLeiden University Medical Center Leiden The Netherlands

6. Department of NephrologyIDIBELL, Hospital Universitari de Bellvitge Barcelona Spain

7. Department of Integrated PharmacoMetrics, PharmacoGenomics and PharmacoKinetics (PMGK), Louvain Drug Research Institute (LDRI)Université Catholique de Louvain (UCL) Brussels Belgium

8. Department of Clinical Pharmacy and ToxicologyLeiden University Medical Center Leiden The Netherlands

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bcp.13838

Reference64 articles.

1. KDIGO clinical practice guideline for the care of kidney transplant recipients;Kidney Disease: Improving Global Outcomes (KDIGO) Transplant Work Group;Am J Transplant,2009

2. Improved Graft Survival after Renal Transplantation in the United States, 1988 to 1996

3. Immunosuppression: Evolution in Practice and Trends, 1994-2004

4. Pharmacogenetics in Transplant Patients

5. CYP3A5 genotype is not associated with a higher risk of acute rejection in tacrolimus-treated renal transplant recipients

Cited by 65 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Individualized dosing parameters for tacrolimus in the presence of voriconazole: a real-world PopPK study;Frontiers in Pharmacology;2024-09-10

2. Dosing strategy of tacrolimus when co-administered with Wuzhi tablet in renal transplant recipients;Int. Journal of Clinical Pharmacology and Therapeutics;2024-08-19

3. Evaluating the evidence for genotype‐informed Bayesian dosing of tacrolimus in children undergoing solid organ transplantation: A systematic literature review;British Journal of Clinical Pharmacology;2024-08-15

4. Prediction of the Intra‐T Lymphocyte Tacrolimus Concentration after Kidney Transplantation with Population Pharmacokinetic Modeling;Clinical Pharmacology & Therapeutics;2024-08-14

5. Steroid–tacrolimus drug–drug interaction and the effect of CYP3A genotypes;British Journal of Clinical Pharmacology;2024-07-12